These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8358507)

  • 1. Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients.
    Alhainen K; Helkala EL; Riekkinen P
    Dementia; 1993; 4(1):54-8. PubMed ID: 8358507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine.
    Alhainen K; Sirviö J; Helkala EL; Reinikainen K; Riekkinen P
    Neurosci Lett; 1991 Sep; 130(1):46-8. PubMed ID: 1684233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
    Riekkinen P; Riekkinen M; Soininen H; Kuikka J; Laakso M; Riekkinen P
    Neuroreport; 1997 May; 8(8):1845-9. PubMed ID: 9223063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.
    Sahakian BJ; Owen AM; Morant NJ; Eagger SA; Boddington S; Crayton L; Crockford HA; Crooks M; Hill K; Levy R
    Psychopharmacology (Berl); 1993; 110(4):395-401. PubMed ID: 7870908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease.
    Alhainen K; Partanen J; Reinikainen K; Laulumaa V; Soininen H; Airaksinen M; Riekkinen P
    Neurosci Lett; 1991 Jun; 127(1):113-6. PubMed ID: 1881606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB.
    Sahakian BJ; Coull JT
    Acta Neurol Scand Suppl; 1993; 149():29-35. PubMed ID: 8128835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease.
    Gustafson L
    Acta Neurol Scand Suppl; 1993; 149(Rand):39-41. PubMed ID: 8128836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease.
    Riekkinen P; Soininen H; Helkala EL; Partanen K; Laakso M; Vanhanen M; Riekkinen P
    Neuroreport; 1995 Jun; 6(9):1297-300. PubMed ID: 7669991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood.
    Vida S; Gauthier L; Gauthier S
    Can J Psychiatry; 1989 Apr; 34(3):165-70. PubMed ID: 2655861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers.
    Weinstein HC; Teunisse S; van Gool WA
    J Neurol; 1991 Feb; 238(1):34-8. PubMed ID: 2030370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.
    Minthon L; Gustafson L; Dalfelt G; Hagberg B; Nilsson K; Risberg J; Rosén I; Seiving B; Wendt PE
    Dementia; 1993; 4(1):32-42. PubMed ID: 8358504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data.
    Amberla K; Nordberg A; Viitanen M; Winblad B
    Acta Neurol Scand Suppl; 1993; 149():55-7. PubMed ID: 8128841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial.
    Querfurth HW; Allam GJ; Geffroy MA; Schiff HB; Kaplan RF
    Dement Geriatr Cogn Disord; 2000; 11(6):314-21. PubMed ID: 11044776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease.
    Molloy DW; Guyatt GH; Wilson DB; Duke R; Rees L; Singer J
    CMAJ; 1991 Jan; 144(1):29-34. PubMed ID: 1984813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.
    Riekkinen M; Soininen H; Riekkinen P; Kuikka J; Laakso M; Helkala EL; Partanen J; Riekkinen P
    Neuroscience; 1998 Mar; 83(2):471-9. PubMed ID: 9460755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.
    Alhainen K; Helkala EL; Reinikainen K; Riekkinen P
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):185-92. PubMed ID: 7690228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
    Wilcock GK; Surmon DJ; Scott M; Boyle M; Mulligan K; Neubauer KA; O'Neill D; Royston VH
    Age Ageing; 1993 Sep; 22(5):316-24. PubMed ID: 8237620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.